JAMA Network

JAMA Network

JAMA Neurology : Phenoconversion in Pure Autonomic Failure

24 min · 4 de may de 202624 min
portada del episodio JAMA Neurology : Phenoconversion in Pure Autonomic Failure

Descripción

Interview with Alessandra Fanciulli, MD, PhD, and Eduardo de Pablo-Fernández, MD, PhD, authors of Phenoconversion in Pure Autonomic Failure: A Systematic Review and Meta-Analysis. Hosted by Cynthia E. Armand, MD. Related Content: * Phenoconversion in Pure Autonomic Failure [https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2026.0989?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * Pure Autonomic Failure and Central Synucleinopathy Risk [https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2026.0986?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y forma parte de la comunidad de JAMA Network!

Prueba gratis

Empieza 7 días de prueba

$99 / mes después de la prueba. · Cancela cuando quieras.

  • Podcasts solo en Podimo
  • 20 horas de audiolibros al mes
  • Podcast gratuitos
Prueba gratis

Todos los episodios

904 episodios

episode JAMA Surgery : Enhanced Recovery Protocol for Children Undergoing Surgery artwork

JAMA Surgery : Enhanced Recovery Protocol for Children Undergoing Surgery

Interview with Mehul V. Raval, MD, MS, MBA, and Jane L. Holl, MD, MPH, authors of Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery: The ENRICH-US Stepped-Wedge Cluster-Randomized Trial. Hosted by Jamie Coleman, MD. Related Content: * Implementation and Effectiveness of an Enhanced Recovery Protocol for Children Undergoing Surgery [https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2026.1382?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * Multicomponent Enhanced Recovery After Surgery—Implementation Affects Effectiveness [https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2026.1381?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

13 de may de 202614 min
episode JAMA Internal Medicine : Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism artwork

JAMA Internal Medicine : Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism

Interview with Shalender Bhasin, MBBS, author of Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism: A Randomized Clinical Trial, and Peter C. Albertsen, MD, author of Collaborating to Improve Quality of Life Among Prostate Cancer Survivors. Hosted by Eve Rittenberg, MD. Related Content: * Testosterone Treatment in Prostate Cancer Survivors With Hypogonadism [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.1343?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * Collaborating to Improve Quality of Life Among Prostate Cancer Survivors [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.1357?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

11 de may de 202613 min
episode JAMA Internal Medicine : Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease artwork

JAMA Internal Medicine : Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease

Interview with Vineet Ahuja, DM, author of Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease: A Randomized Trial and Michael H. Woodworth, MD, MSc, author of Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption? Hosted by Ilana Richman, MD, MHS. Related Content: * Fecal Microbiota Transplant and Multidrug-Resistant Organism Decolonization in Gastrointestinal Disease [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.0655?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links] * Fecal Microbiota Transplant for Multidrug Resistance—No Benefit Without Disruption? [https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.0668?utm_source=podcast_platforms&utm_medium=referral&utm_campaign=related_article_links]

20 de abr de 202614 min